Lancome Paris Clarifique Bx-interceptor Topical Acne Clearing Treatment Liquid
Product Images NDC 82046-955

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lancome Paris Clarifique Bx-interceptor Topical Acne Clearing Treatment (NDC 82046-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by L�oreal Usa Products Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 mL Carton (30 mL Carton)

Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment is a 30 ml (1 fl. oz.) topical liquid acne medication with 2% salicylic acid, manufactured by L'Oreal USA Products Inc. The label highlights its anti-acne formulation with additional ingredients including vitamin B5, niacinamide, glycolic acid, azelaic acid derivative, and Bixa-Beech extract. The packaging is primarily gray with black text and includes usage directions and warnings.*

FDA Label Image

Product (Product)

Lancome Paris Clarifique BX-Interceptor Topical Acne Clearing Treatment in a clear cylindrical bottle with a silver and light blue label. The label shows the brand name Lancome and product name Clarifique BX-Interceptor. The bottle has a white and silver-top dropper cap and a visible dropper applicator beside it. The product is a topical liquid indicated as 2% Salicylic Acid acne medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.